Get the Stockscreener App
1.31
0.76%
-0.01
Biovie Inc stock is traded at $1.31, with a volume of 28,849.
It is down -0.76% in the last 24 hours and up +1.55% over the past month.
BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.
See More
Previous Close:
$1.32
Open:
$1.35
24h Volume:
28,849
Relative Volume:
0.28
Market Cap:
$9.88M
Revenue:
-
Net Income/Loss:
$-17.43M
P/E Ratio:
-0.3518
EPS:
-3.7237
Net Cash Flow:
$-14.32M
1W Performance:
-7.09%
1M Performance:
+1.55%
6M Performance:
-27.22%
1Y Performance:
+16.96%
1-Day Range:
$1.30
$1.3599
1-Week Range:
$1.20
$1.46
52-Week Range:
$0.62
$9.56
Biovie Inc Stock (BIVI) Company Profile
Name
Biovie Inc
Sector
Industry
Phone
775-888-3162
Address
680 W NYE LANE, CARSON CITY
Compare BIVI vs VRTX, REGN, ALNY, ARGX, INSM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BIVI
Biovie Inc
|
1.31 | 9.95M | 0 | -17.43M | -14.32M | -3.7237 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 115.58B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 79.23B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 43.59B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 43.26B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 31.97B | 606.42M | -1.28B | -997.58M | -6.403 |
Biovie Inc Stock (BIVI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-22-22 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-15-21 | Initiated | B. Riley Securities | Buy |
Biovie Inc Stock (BIVI) Latest News
BioVie targets Parkinson’s at its source with lead drug bezisterim - Proactive Investors
Cuong Do Discloses Investment at BioVie Inc. with 5.03% Stake - TradingView
BioVie (NASDAQ: BIVI) CEO Cuong Do discloses 5.03% share stake - Stock Titan
If You Invested $1,000 in Biovie Inc (BIVI) - Stock Titan
BIVI Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
US Market Wrap: Will BioVie Inc stock go up in YEAREarnings Recap Summary & Free Safe Capital Growth Stock Tips - baoquankhu1.vn
BioVie Announces Abstract Accepted for Presentation at AD/PD 2026 - Bitget
BioVie to present Parkinson’s study data at AD/PD 2026 conference - Proactive financial news
Parkinson’s trial drug heads to 2026 Alzheimer’s & Parkinson’s meeting - Stock Titan
BIVI SEC FilingsBiovie Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Nexalin Technology and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Green Bay Press-Gazette
BioVie Inc. (BIVI) Discusses Clinical Progress of - One News Page
BioVie Inc. (BIVI) Competitors - Meyka
BIVI,CYRX Dividends - Finviz
BioVie (BIVIW) 10K Form and SEC Filings 2026 - MarketBeat
BioVie (BIVIW) Stock Price, News & Analysis - MarketBeat
BioVie (BIVIW) Stock Chart and Price History 2026 - MarketBeat
BioVie (BIVIW) Stock Trends and Sentiment 2026 - MarketBeat
Top BioVie (BIVIW) Competitors 2026 - MarketBeat
Interview with the President and CEO: BioVie Inc. (NASDAQ:BIVI) - The Wall Street Transcript
BIVI Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
New to The Street Broadcasts Tonight on Bloomberg at 6:30 PM EST Featuring Roadzen, BioVie, and TY J Young Wealth - The Destin Log
New to The Street Broadcasts Show #716 Tonight at 6:30 PM ET on Bloomberg Television Featuring Stardust Power (NASDAQ:SDST), BioVie (NASDAQ:BIVI), Roadzen (NASDAQ:RDZN), with Special Segments from Kelsey Grammer on KAREN and Andrew - Newport Daily News
60 Degrees Pharmaceuticals and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - ACCESS Newswire
BIVIW Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
BioVie to host investor webinar on March 4 - Proactive Investors
Join Biovie's Exclusive Live Investor Webinar and Q&A Session on March 4 - Bitget
Join Biovie’s Exclusive Live Investor Webinar and Q&A Session on March 4 - The Manila Times
Aug Shorts: Will BioVie Inc stock go up in YEARMarket Sentiment Review & Entry and Exit Point Strategies - baoquankhu1.vn
BioVie stock dips on pricing $12M securities offering - MSN
BioVie Inc. (NASDAQ:BIVI) Sees Significant Increase in Short Interest - Defense World
Why BioVie Inc. stock is recommended by analystsPortfolio Gains Report & Weekly High Return Stock Opportunities - mfd.ru
Small cap wrap: BioVie, VivoPower, NanoViricides, Aftermath Silver... - Proactive Investors
BioVie Announces Abstracts Accepted for Presentation at the 2026 American College of Psychiatrists Annual Meeting - Bitget
Halper Sadeh LLC Encourages BioVie Inc. Shareholders to Contact the Firm to Discuss Their Rights - GlobeNewswire
BioVie highlights bezisterim research at ACP meeting - Yahoo! Finance Canada
BioVie could offer first new Parkinson’s therapy in decades - Yahoo! Finance Canada
EV Market: Is BioVie Inc a turnaround storyQuarterly Growth Report & Free Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Key facts: BioVie Inc. reports $6.1M Q4 loss; faces operational issues - TradingView
BIOVIE INC. SEC 10-Q Report - TradingView
BIVI: Net loss narrowed, cash bolstered by $10.5M raise, but going concern risks persist - TradingView
Aug Sentiment: Will BioVie Inc stock go up in YEARTrade Entry Report & Low Risk High Win Rate Stock Picks - baoquankhu1.vn
Setup Watch: Will BioVie Inc stock go up in YEARWeekly Trading Summary & Weekly Watchlist of Top Performers - baoquankhu1.vn
Trading Recap: What are the analyst revisions for BioVie IncIs Olympic Steel Inc stock a good investment in YEARForecast Cut & Short-Term High Return Ideas - baoquankhu1.vn
Biovie Inc Stock (BIVI) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.82%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):